Interstitial lung disease after receiving the mRNA-based COVID-19 vaccine tozinameran

Tozinameran, a messenger ribonucleic acid (mRNA)-based coronavirus disease 19 (COVID-19) vaccine, has a favorable safety profile and is highly efficacious in preventing COVID-19. Adverse reactions such as pain at the vaccination site, fever, malaise, headache, rash, and anaphylaxis have been commonl...

Descripción completa

Detalles Bibliográficos
Autores principales: Oda, Naohiro, Mitani, Reo, Takata, Ichiro, Kataoka, Mikio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858430/
https://www.ncbi.nlm.nih.gov/pubmed/35223425
http://dx.doi.org/10.1016/j.rmcr.2022.101618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858430/
https://www.ncbi.nlm.nih.gov/pubmed/35223425
http://dx.doi.org/10.1016/j.rmcr.2022.101618

Ejemplares similares